Felix Baker, Director at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 119,062 shares at $121.37 ($14.5M) on 2019-05-29, disclosed to the SEC on 2019-05-30.
Open-market sale of $14.5M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.37 | 4,772 | $579K | 4.0% |
| 2 | $121.37 | 39,732 | $4.8M | 33.1% |
| 3 | $122.37 | 4,300 | $526K | 3.6% |
| 4 | $122.37 | 35,796 | $4.4M | 30.1% |
| 5 | $123.06 | 3,696 | $455K | 3.1% |
| 6 | $123.06 | 30,766 |
| $3.8M |
| 26.0% |
| Total | $122.20 avg | 119,062 | $14.5M | 100% |
| Filing → |
| MDGL | BUY | 2025-08-20 | $48.5M | — | Filing → |
| KALA | BUY | 2024-12-31 | $4.0M | — | Filing → |
| MDGL | BUY | 2023-11-15 | $31.4M | — | Filing → |